Archive - Hillope Capital Letters

H1 2024 Results and Thoughts

People call it Value Investing, I call it Company Investing

Aug 6, 2024 •

Hillope Capital

May 2024

Full Year 2023 Results and Thoughts

Patience, my friend, Patience ...

May 27, 2024 •

Hillope Capital

November 2023

Q3 2023 Results and Thoughts

Dear Investors,

Nov 20, 2023 •

Hillope Capital

September 2023

Q2 2023 Results and Thoughts

Dear Investors,

Sep 11, 2023 •

Hillope Capital

June 2023

Q1 2023 Results and Thoughts

Jun 6, 2023 •

Hillope Capital

December 2022

New Journey in 2023 - Hillope Capital Letters

A formal investor letter to track my performance and share my thoughts

Dec 31, 2022 •

Hillope Capital

January 2022

Berkshire Hathaway vs. KKR

The key differences between value investing and private equity

Jan 13, 2022 •

Hillope Capital

August 2021

AK Medical/爱康医疗 (HK: 1789)

A Leading Orthopaedic Implants Business in China

Aug 23, 2021 •

Hillope Capital

July 2021

A Black Swan Event on Renrui?

Jul 7, 2021 •

Hillope Capital

April 2021

Renrui HR / 人瑞人才 (HK: 6919)

Leading flexible staffing provider in China; huge macro-economic tailwind; excellent ROIC; Strong owner-operator with various growth optionality

Apr 25, 2021 •

Hillope Capital

March 2021

The Most Important Traits of a Great Investor

Welcome to my first post! In this post, I want to share with you my thoughts on what makes a great investor, the concept of dual-traits and how it…

Mar 2, 2021 •

Hillope Capital

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts